Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Suv39h1em1/Cya
Common Name:
Suv39h1-KO
Product ID:
S-KO-20233
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Suv39h1-KO
Strain ID
KOCMP-20937-Suv39h1-B6J-VA
Gene Name
Suv39h1
Product ID
S-KO-20233
Gene Alias
DXHXS7466e; H3-K9-HMTase 1; KMT1A; mIS6
Background
C57BL/6JCya
NCBI ID
20937
Modification
Conventional knockout
Chromosome
X
Phenotype
MGI:1099440
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Suv39h1em1/Cya mice (Catalog S-KO-20233) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000115638
NCBI RefSeq
NM_011514
Target Region
Exon 2~3
Size of Effective Region
~2.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Suv39h1, a lysine methyltransferase, is known for its role in introducing di-and trimethylation at histone H3 lysine 9 (H3K9), which is crucial for maintaining heterochromatin and gene repression. It contains a catalytic SET domain and a chromodomain, and is involved in multiple biological pathways. Genetic models, such as KO/CKO mouse models, have been valuable in studying its functions [7].

In liver fibrosis, HSC-specific or myofibroblast-specific deletion of Suv39h1 in mice ameliorated liver fibrosis. Suv39h1 expression was upregulated during HSC-myofibroblast transition, and its knockdown blocked this transition in vitro. Mechanistically, Suv39h1 bound to the promoter of heme oxygenase 1 (HMOX1) and repressed its transcription [1].

In adoptive T-cell therapies, genetic disruption of SUV39H1 enhanced the early expansion, long-term persistence, and antitumor efficacy of human CAR T cells in leukemia and prostate cancer models. It also optimized the long-term functional persistence of BBz-CAR T cells in solid tumor models, protecting against relapses and rechallenges [2,3].

In limb ischemia of mice, pharmaceutical inhibition or genetic deletion of SUV39H1 improved blood perfusion, capillary density, and angiogenesis in ischemic muscle tissue [4].

In liver ischemia-reperfusion injury, global or hepatocyte conditional Suv39h1 KO mice were protected from the injury [5].

In MLL-AF9-induced acute myeloid leukemia, Suv39h1 overexpression increased leukemia latency and decreased the frequency of LSCs, while knockdown accelerated disease progression [6].

In glioblastoma, knockdown of SUV39H1 in patient-derived GSCs impaired their proliferation and stemness, and targeting SUV39H1 in vivo inhibited GSC-driven tumor formation [8].

In summary, Suv39h1 plays essential roles in multiple biological processes and disease conditions. KO/CKO mouse models have been instrumental in revealing its functions in diseases like liver fibrosis, cancer, limb ischemia, and liver ischemia-reperfusion injury, offering potential therapeutic targets for these conditions.

References:
1. Kong, Ming, Zhou, Junjing, Kang, Aoqi, Xu, Yong, Li, Zilong. 2024. Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis. In Gut, 73, 810-824. doi:10.1136/gutjnl-2023-329671. https://pubmed.ncbi.nlm.nih.gov/38176898/
2. Jain, Nayan, Zhao, Zeguo, Koche, Richard P, Giavridis, Theodoros, Sadelain, Michel. . Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function. In Cancer discovery, 14, 142-157. doi:10.1158/2159-8290.CD-22-1319. https://pubmed.ncbi.nlm.nih.gov/37934007/
3. López-Cobo, Sheila, Fuentealba, Jaime R, Gueguen, Paul, Saitakis, Michael, Amigorena, Sebastian. . SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors. In Cancer discovery, 14, 120-141. doi:10.1158/2159-8290.CD-22-1350. https://pubmed.ncbi.nlm.nih.gov/37934001/
4. Niu, Wenhao, Cao, Wenyue, Wu, Feng, Liang, Chun. . SUV39H1 Inhibits Angiogenesis in Limb Ischemia of Mice. In Cell transplantation, 32, 9636897231198167. doi:10.1177/09636897231198167. https://pubmed.ncbi.nlm.nih.gov/37811706/
5. Li, Zilong, Li, Jichen, Wu, Meng, Qin, Lei, Fan, Zhiwen. 2024. Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injury. In Redox biology, 78, 103414. doi:10.1016/j.redox.2024.103414. https://pubmed.ncbi.nlm.nih.gov/39603205/
6. Chu, Yajing, Chen, Yangpeng, Guo, Huidong, Shi, Jun, Yuan, Weiping. 2020. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia. In Oncogene, 39, 7239-7252. doi:10.1038/s41388-020-01495-6. https://pubmed.ncbi.nlm.nih.gov/33037410/
7. Weirich, Sara, Khella, Mina S, Jeltsch, Albert. 2021. Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases. In Life (Basel, Switzerland), 11, . doi:10.3390/life11070703. https://pubmed.ncbi.nlm.nih.gov/34357075/
8. Li, Chunying, Xie, Qiqi, Ghosh, Sugata, Nephew, Kenneth P, Shen, Jia. 2024. SUV39H1 Preserves Cancer Stem Cell Chromatin State and Properties in Glioblastoma. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.08.15.607856. https://pubmed.ncbi.nlm.nih.gov/39229036/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest